KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Imax (IMAX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Imax (IMAX) over the last 16 years, with Q3 2025 value amounting to $143.1 million.

  • Imax's Cash & Equivalents rose 3693.83% to $143.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.1 million, marking a year-over-year increase of 3693.83%. This contributed to the annual value of $100.6 million for FY2024, which is 3202.1% up from last year.
  • Imax's Cash & Equivalents amounted to $143.1 million in Q3 2025, which was up 3693.83% from $109.3 million recorded in Q2 2025.
  • Imax's 5-year Cash & Equivalents high stood at $267.8 million for Q1 2021, and its period low was $76.2 million during Q4 2023.
  • Over the past 5 years, Imax's median Cash & Equivalents value was $104.5 million (recorded in 2024), while the average stood at $127.9 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 5482.05% in 2022, then soared by 3693.83% in 2025.
  • Imax's Cash & Equivalents (Quarter) stood at $189.7 million in 2021, then plummeted by 48.66% to $97.4 million in 2022, then decreased by 21.77% to $76.2 million in 2023, then surged by 32.02% to $100.6 million in 2024, then surged by 42.25% to $143.1 million in 2025.
  • Its last three reported values are $143.1 million in Q3 2025, $109.3 million for Q2 2025, and $97.1 million during Q1 2025.